Table 1. Pre- and postcryopreservation... | American Society of Hematology

Table 1.

Pre- and postcryopreservation characteristics of products

	n	Median	Range
Precryopreservation
Transit time, h	305	26	0.25-85
Product volume, mL
HPC-A	288	263	42-751
HPC-M	17	892	92-2040
Product WCC, ×10⁹/L	305	222	13-901
CD34⁺ cell viability, %	96	99	73-100
Postcryopreservation
CD34⁺ cell recovery, %
Total	305	76	6-122
HPC-A	288	75	6-122
HPC-M	17	87	36-110
Infused as HPCs*	80	82	34-119
Infused as DLI	17	68	6-96
Stored	187	72	7-122
Disposed	7	85	31-99
CD34⁺ cell viability, %
Total	139	87	6-99
HPC-A	135	91	6-99
HPC-M	4	84	17-91
Infused as HPCs*	61	95	47-99
Infused as DLI	6	84	6-94
Stored	59	89	13-98
Disposed	7	91	42-97
CD34⁺ cells, ×10⁶/kg per recipient
Total	297	3.1	0.1-20
HPC-A	280	3.1	0.1-18.7
HPC-M	17	2.6	0.2-20
Infused as HPCs*	80	5	0.94-15.7
Infused as donor leukocytes	16	5.3	1.9-16.8
Stored	184	3.4	0.6-19.5
Disposed	7	3.4	1.2-7.2

	n	Median	Range
Precryopreservation
Transit time, h	305	26	0.25-85
Product volume, mL
HPC-A	288	263	42-751
HPC-M	17	892	92-2040
Product WCC, ×10⁹/L	305	222	13-901
CD34⁺ cell viability, %	96	99	73-100
Postcryopreservation
CD34⁺ cell recovery, %
Total	305	76	6-122
HPC-A	288	75	6-122
HPC-M	17	87	36-110
Infused as HPCs*	80	82	34-119
Infused as DLI	17	68	6-96
Stored	187	72	7-122
Disposed	7	85	31-99
CD34⁺ cell viability, %
Total	139	87	6-99
HPC-A	135	91	6-99
HPC-M	4	84	17-91
Infused as HPCs*	61	95	47-99
Infused as DLI	6	84	6-94
Stored	59	89	13-98
Disposed	7	91	42-97
CD34⁺ cells, ×10⁶/kg per recipient
Total	297	3.1	0.1-20
HPC-A	280	3.1	0.1-18.7
HPC-M	17	2.6	0.2-20
Infused as HPCs*	80	5	0.94-15.7
Infused as donor leukocytes	16	5.3	1.9-16.8
Stored	184	3.4	0.6-19.5
Disposed	7	3.4	1.2-7.2

n = 14 products combined at infusion and excluded from this summary.